XD2-149

N/A

Report date: 2022/04/12 16:35:45
NME

Base Information

Drug NameXD2-149
Drug Alias NameXD2-149
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProtein cereblon/E3 ubiquitin-protein ligase ZFP91 degradersQuinone reductase 1 inhibitors
TargetsProtein cereblon/E3 ubiquitin-protein ligase ZFP91Quinone reductase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A